Notizia

The latest pharma, healthcare and biotech news on drug approvals, clinical trial failures, big pharma mergers and licensing of drugs.

Omega’s sixth funding round; Correvio’s drug failure; and BIMA acquisition

Business Consultant, DelveInsight's Oncology based Reports, Notizia, Pharma Consultant, The Business Cocktail

A leading global international investment firm, Omega Funds has announced the closure of its sixth fundraising USD 438 Million. More than...

Read More

Acquisition of ArQule; Synthorx; and Zentalis nabs a raise

Business Consultant, DelveInsight's Drug Report, Notizia, Oncology based Indications, Pharma Consultant, The Business Cocktail

Merck is set to complete the already planned purchase of the ArQule for USD 2.7 Billion. Under the terms of the agreement, Merck will pay...

Read More

Toujeo to treat Type 1 Diabetes; TauRx for Alzheimer’s patients

Business Consultant, DelveInsight's Drug Report, Notizia, Pharma Consultant, The Business Cocktail

Sanofi’s Toujeo has received FDA recommendation for its expanded use in Type 1 Diabetes. Toujeo is an insulin glargine injection to...

Read More

Novartis buys Medicines Co. for USD 9.7 Billion

Business Consultant, DelveInsight's Indication Pipeline Reports, Notizia, Pharma Consultant, The Business Cocktail

Novartis plans to buy The Medicines Company for USD 9.7 Billion to gain access to a heart drug inclisiran, almost ready to get into the...

Read More

Nordisk ties up with Dicerna; Pfizer’s drug gets FDA nod

Business Consultant, DelveInsight's Drug Report, Notizia, Pharma Consultant, The Business Cocktail

Novo Nordisk has announced to enter into a collaboration with Dicerna’s RNAi platform to focus on metabolic and liver-related diseases....

Read More

AbbVie Sells bonds to Fund Allergan takeover

Business Consultant, DelveInsight's Indication Pipeline Reports, Notizia, Pharma Consultant, The Business Cocktail

AbbVie has traded off its bonds worth USD 30 Billion to finance the purchase of the Allergan.   AbbVie this year in June has agreed to...

Read More
Close